Multisystem inflammatory syndrome in systemic lupus erythematosus patient with COVID-19: Case report and review.

Multisystem inflammatory syndrome in adults (MIS-A) is considered a rare and serious complication of coronavirus disease 2019, which more frequently occurs in young, male, and either non-Hispanic black or Hispanic persons. Here we present a Chinese woman aged 50 years with systemic lupus erythematosus diagnosed with MIS-A. She experienced unexpected sudden cardiac and liver injuries and hemodynamic collapse, and her platelet count dropped sharply on hospital day 2. Unfortunately, the patient's condition gradually deteriorated despite maximum support and she died on day 3. We present this rare case to emphasize that MIS-A in autoimmune diseases may be more severe and its management may be more difficult.

[1]  B. McCrindle,et al.  Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children , 2023, Canadian Journal of Cardiology.

[2]  Yingchuan Li,et al.  Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China , 2023, Journal of Infection and Public Health.

[3]  P. Patel,et al.  Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults , 2021, JAMA network open.

[4]  Tadaki Suzuki,et al.  Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective , 2021, JMA journal.

[5]  L. Waddell,et al.  Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review. , 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[6]  S. Choi,et al.  The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea , 2021, Journal of Korean medical science.

[7]  I. Al Busaidi,et al.  Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man , 2021, Cureus.

[8]  T. Eguchi,et al.  Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan , 2021, Emerging infectious diseases.

[9]  H. Bodur,et al.  Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent , 2021, Rheumatology International.

[10]  M. Stevenson,et al.  Recovery does not always signal the end of the battle: A case of post SARS-CoV-2 multisystem inflammatory syndrome in an adult , 2021, IDCases.

[11]  P. Moceri,et al.  Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data , 2021, Vaccine.

[12]  T. Niewold,et al.  COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease , 2020, Translational Research.

[13]  C. Newton-Cheh,et al.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[14]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[15]  J. Alcocer-Varela,et al.  The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients , 2019, Front. Immunol..

[16]  OUP accepted manuscript , 2022, Clinical Infectious Diseases.